3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Leukemia, Myeloid, Acute
35
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma
27
Lymphoma, Non-Hodgkin
22
Burkitt Lymphoma
21
Lymphoma, Mantle-Cell
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, Follicular
19
Neuroblastoma
18
Myelodysplastic Syndromes
18
Multiple Myeloma
18
Lymphoma, Large-Cell, Immunoblastic
17
Lymphoma, B-Cell, Marginal Zone
17
Hodgkin Disease
15
Astrocytoma
14
Medulloblastoma
13
Breast Neoplasms
13
Recurrence
12
Central Nervous System Neoplasms
12
Sarcoma
11
Myeloproliferative Disorders
10
Leukemia, Myeloid, Chronic-Phase
10
Ovarian Neoplasms
9
Leukemia, Myeloid, Accelerated Phase
9
Familial ependymoma
9
Carcinoma, Ovarian Epithelial
9
Blast Crisis
9
Optic Nerve Glioma
8
Interventions
venetoclax
1
vandetanib
1
tremelimumab
1
ricolinostat
1
pomalidomide
1
pembrolizumab
1
pazopanib
1
niraparib
1
ibrutinib
1
enzastaurin
1
durvalumab
1
copanlisib
1
brigatinib
1
binimetinib
1
avasopasem manganese
1
abexinostat
1
Transplantation, Autologous
1
Steroids
1
Melphalan
1
Interleukin-2
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Dexamethasone
1
Blood Specimen Collection
1
Biopsy
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Disease Progression
×
Filgrastim
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts